Phase II study of cystemustine in advanced head and neck cancer. A trial of the EORTC Clinical Screening Group.
Cappelaere
P
P
Lentz
M A
MA
Degardin
M
M
Chauvergne
J
J
Mayer
F
F
Chollet
P
P
Chevallier
B
B
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009607:Nitrosourea Compounds / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; C051263:N'-(2-chloroethyl)-N-(2-(methylsulfonyl)ethyl)-N'-nitrosourea